0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Avian Influenza Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-11161
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Avian Influenza Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Avian Influenza Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11161
Report
March 2024
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Avian Influenza Vaccines - Market Size

The global market for Avian Influenza Vaccines was estimated to be worth US$ 949 million in 2023 and is forecast to a readjusted size of US$ 1386.6 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Avian Influenza Vaccines - Market

Avian Influenza Vaccines - Market

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.
In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Avian Influenza Vaccines by region & country, by Type, and by Application.
The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.
Market Segmentation

Scope of Avian Influenza Vaccines - Market Report

Report Metric Details
Report Name Avian Influenza Vaccines - Market
Forecasted market size in 2030 US$ 1386.6 million
CAGR 5.5%
Forecasted years 2024 - 2030
Segment by Type:
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Segment by Application
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco (Lohmann ), Yebio, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, ChengDu Tecbond, Sindh Poultry Vaccine Centre, Merck Animal Health, Medion, Avimex Animal Health, JOVAC, Bio-Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Avian Influenza Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Avian Influenza Vaccines - Market size in 2030?

Ans: The Avian Influenza Vaccines - Market size in 2030 will be US$ 1386.6 million.

What is the market share of major companies in Avian Influenza Vaccines - Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Avian Influenza Vaccines - Market share by region?

Ans: China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Who are the main players in the Avian Influenza Vaccines - Market report?

Ans: The main players in the Avian Influenza Vaccines - Market are Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco (Lohmann ), Yebio, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, ChengDu Tecbond, Sindh Poultry Vaccine Centre, Merck Animal Health, Medion, Avimex Animal Health, JOVAC, Bio-Labs

What are the Application segmentation covered in the Avian Influenza Vaccines - Market report?

Ans: The Applications covered in the Avian Influenza Vaccines - Market report are Chicken Avian Influenza Vaccines, Duck & Goose Avian Influenza Vaccines, Other

What are the Type segmentation covered in the Avian Influenza Vaccines - Market report?

Ans: The Types covered in the Avian Influenza Vaccines - Market report are H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines

1 Market Overview
1.1 Avian Influenza Vaccines Product Introduction
1.2 Global Avian Influenza Vaccines Market Size Forecast
1.2.1 Global Avian Influenza Vaccines Sales Value (2019-2030)
1.2.2 Global Avian Influenza Vaccines Sales Volume (2019-2030)
1.2.3 Global Avian Influenza Vaccines Sales Price (2019-2030)
1.3 Avian Influenza Vaccines Market Trends & Drivers
1.3.1 Avian Influenza Vaccines Industry Trends
1.3.2 Avian Influenza Vaccines Market Drivers & Opportunity
1.3.3 Avian Influenza Vaccines Market Challenges
1.3.4 Avian Influenza Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Avian Influenza Vaccines Players Revenue Ranking (2023)
2.2 Global Avian Influenza Vaccines Revenue by Company (2019-2024)
2.3 Global Avian Influenza Vaccines Players Sales Volume Ranking (2023)
2.4 Global Avian Influenza Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Avian Influenza Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Avian Influenza Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Avian Influenza Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Avian Influenza Vaccines
2.9 Avian Influenza Vaccines Market Competitive Analysis
2.9.1 Avian Influenza Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Avian Influenza Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 H5+H7 Avian Influenza Vaccines
3.1.2 H9 Avian Influenza Vaccines
3.2 Global Avian Influenza Vaccines Sales Value by Type
3.2.1 Global Avian Influenza Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Avian Influenza Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Avian Influenza Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Avian Influenza Vaccines Sales Volume by Type
3.3.1 Global Avian Influenza Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Avian Influenza Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Avian Influenza Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Avian Influenza Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chicken Avian Influenza Vaccines
4.1.2 Duck & Goose Avian Influenza Vaccines
4.1.3 Other
4.2 Global Avian Influenza Vaccines Sales Value by Application
4.2.1 Global Avian Influenza Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Avian Influenza Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Avian Influenza Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Avian Influenza Vaccines Sales Volume by Application
4.3.1 Global Avian Influenza Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Avian Influenza Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Avian Influenza Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Avian Influenza Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Avian Influenza Vaccines Sales Value by Region
5.1.1 Global Avian Influenza Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Avian Influenza Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Avian Influenza Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Avian Influenza Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Avian Influenza Vaccines Sales Volume by Region
5.2.1 Global Avian Influenza Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Avian Influenza Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Avian Influenza Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Avian Influenza Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Avian Influenza Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Avian Influenza Vaccines Sales Value, 2019-2030
5.4.2 North America Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Avian Influenza Vaccines Sales Value, 2019-2030
5.5.2 Europe Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Avian Influenza Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Avian Influenza Vaccines Sales Value, 2019-2030
5.7.2 South America Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Avian Influenza Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Avian Influenza Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Avian Influenza Vaccines Sales Value
6.2.1 Key Countries/Regions Avian Influenza Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Avian Influenza Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Avian Influenza Vaccines Sales Value, 2019-2030
6.3.2 United States Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Avian Influenza Vaccines Sales Value, 2019-2030
6.4.2 Europe Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Avian Influenza Vaccines Sales Value, 2019-2030
6.5.2 China Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Avian Influenza Vaccines Sales Value, 2019-2030
6.6.2 Japan Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Avian Influenza Vaccines Sales Value, 2019-2030
6.7.2 South Korea Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Avian Influenza Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Avian Influenza Vaccines Sales Value, 2019-2030
6.9.2 India Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Avian Influenza Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merial
7.1.1 Merial Company Information
7.1.2 Merial Introduction and Business Overview
7.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merial Avian Influenza Vaccines Product Offerings
7.1.5 Merial Recent Development
7.2 QYH Biotech
7.2.1 QYH Biotech Company Information
7.2.2 QYH Biotech Introduction and Business Overview
7.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 QYH Biotech Avian Influenza Vaccines Product Offerings
7.2.5 QYH Biotech Recent Development
7.3 DHN
7.3.1 DHN Company Information
7.3.2 DHN Introduction and Business Overview
7.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DHN Avian Influenza Vaccines Product Offerings
7.3.5 DHN Recent Development
7.4 HVRI
7.4.1 HVRI Company Information
7.4.2 HVRI Introduction and Business Overview
7.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 HVRI Avian Influenza Vaccines Product Offerings
7.4.5 HVRI Recent Development
7.5 CEVA
7.5.1 CEVA Company Information
7.5.2 CEVA Introduction and Business Overview
7.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CEVA Avian Influenza Vaccines Product Offerings
7.5.5 CEVA Recent Development
7.6 Elanco (Lohmann )
7.6.1 Elanco (Lohmann ) Company Information
7.6.2 Elanco (Lohmann ) Introduction and Business Overview
7.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Offerings
7.6.5 Elanco (Lohmann ) Recent Development
7.7 Yebio
7.7.1 Yebio Company Information
7.7.2 Yebio Introduction and Business Overview
7.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Yebio Avian Influenza Vaccines Product Offerings
7.7.5 Yebio Recent Development
7.8 Zoetis
7.8.1 Zoetis Company Information
7.8.2 Zoetis Introduction and Business Overview
7.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zoetis Avian Influenza Vaccines Product Offerings
7.8.5 Zoetis Recent Development
7.9 FATRO
7.9.1 FATRO Company Information
7.9.2 FATRO Introduction and Business Overview
7.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 FATRO Avian Influenza Vaccines Product Offerings
7.9.5 FATRO Recent Development
7.10 Kyoto Biken
7.10.1 Kyoto Biken Company Information
7.10.2 Kyoto Biken Introduction and Business Overview
7.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Kyoto Biken Avian Influenza Vaccines Product Offerings
7.10.5 Kyoto Biken Recent Development
7.11 CAVAC
7.11.1 CAVAC Company Information
7.11.2 CAVAC Introduction and Business Overview
7.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CAVAC Avian Influenza Vaccines Product Offerings
7.11.5 CAVAC Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Introduction and Business Overview
7.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Avian Influenza Vaccines Product Offerings
7.12.5 Ringpu Biology Recent Development
7.13 Vaksindo
7.13.1 Vaksindo Company Information
7.13.2 Vaksindo Introduction and Business Overview
7.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Vaksindo Avian Influenza Vaccines Product Offerings
7.13.5 Vaksindo Recent Development
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Company Information
7.14.2 ChengDu Tecbond Introduction and Business Overview
7.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Offerings
7.14.5 ChengDu Tecbond Recent Development
7.15 Sindh Poultry Vaccine Centre
7.15.1 Sindh Poultry Vaccine Centre Company Information
7.15.2 Sindh Poultry Vaccine Centre Introduction and Business Overview
7.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offerings
7.15.5 Sindh Poultry Vaccine Centre Recent Development
7.16 Merck Animal Health
7.16.1 Merck Animal Health Company Information
7.16.2 Merck Animal Health Introduction and Business Overview
7.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Merck Animal Health Avian Influenza Vaccines Product Offerings
7.16.5 Merck Animal Health Recent Development
7.17 Medion
7.17.1 Medion Company Information
7.17.2 Medion Introduction and Business Overview
7.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Medion Avian Influenza Vaccines Product Offerings
7.17.5 Medion Recent Development
7.18 Avimex Animal Health
7.18.1 Avimex Animal Health Company Information
7.18.2 Avimex Animal Health Introduction and Business Overview
7.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Avimex Animal Health Avian Influenza Vaccines Product Offerings
7.18.5 Avimex Animal Health Recent Development
7.19 JOVAC
7.19.1 JOVAC Company Information
7.19.2 JOVAC Introduction and Business Overview
7.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.19.4 JOVAC Avian Influenza Vaccines Product Offerings
7.19.5 JOVAC Recent Development
7.20 Bio-Labs
7.20.1 Bio-Labs Company Information
7.20.2 Bio-Labs Introduction and Business Overview
7.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Bio-Labs Avian Influenza Vaccines Product Offerings
7.20.5 Bio-Labs Recent Development
8 Industry Chain Analysis
8.1 Avian Influenza Vaccines Industrial Chain
8.2 Avian Influenza Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Avian Influenza Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Avian Influenza Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Avian Influenza Vaccines Market Trends
    Table 2. Avian Influenza Vaccines Market Drivers & Opportunity
    Table 3. Avian Influenza Vaccines Market Challenges
    Table 4. Avian Influenza Vaccines Market Restraints
    Table 5. Global Avian Influenza Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Avian Influenza Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Avian Influenza Vaccines Sales Volume by Company (2019-2024) & (M Doses)
    Table 8. Global Avian Influenza Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Avian Influenza Vaccines Price by Company (2019-2024) & (USD/K Doses)
    Table 10. Key Manufacturers Avian Influenza Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Avian Influenza Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Avian Influenza Vaccines
    Table 13. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Avian Influenza Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Avian Influenza Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Avian Influenza Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Avian Influenza Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)
    Table 22. Global Avian Influenza Vaccines Sales Volume by Type (2019-2024) & (M Doses)
    Table 23. Global Avian Influenza Vaccines Sales Volume by Type (2025-2030) & (M Doses)
    Table 24. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Avian Influenza Vaccines Price by Type (2019-2024) & (USD/K Doses)
    Table 27. Global Avian Influenza Vaccines Price by Type (2025-2030) & (USD/K Doses)
    Table 28. Global Avian Influenza Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Avian Influenza Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Avian Influenza Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Avian Influenza Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)
    Table 34. Global Avian Influenza Vaccines Sales Volume by Application (2019-2024) & (M Doses)
    Table 35. Global Avian Influenza Vaccines Sales Volume by Application (2025-2030) & (M Doses)
    Table 36. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Avian Influenza Vaccines Price by Application (2019-2024) & (USD/K Doses)
    Table 39. Global Avian Influenza Vaccines Price by Application (2025-2030) & (USD/K Doses)
    Table 40. Global Avian Influenza Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Avian Influenza Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Avian Influenza Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Avian Influenza Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Avian Influenza Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Avian Influenza Vaccines Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030
    Table 46. Global Avian Influenza Vaccines Sales Volume by Region (2019-2024) & (M Doses)
    Table 47. Global Avian Influenza Vaccines Sales Volume by Region (2025-2030) & (M Doses)
    Table 48. Global Avian Influenza Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Avian Influenza Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Avian Influenza Vaccines Average Price by Region (2019-2024) & (USD/K Doses)
    Table 51. Global Avian Influenza Vaccines Average Price by Region (2025-2030) & (USD/K Doses)
    Table 52. Key Countries/Regions Avian Influenza Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Avian Influenza Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Avian Influenza Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Avian Influenza Vaccines Sales Volume, (2019-2024) & (M Doses)
    Table 56. Key Countries/Regions Avian Influenza Vaccines Sales Volume, (2025-2030) & (M Doses)
    Table 57. Merial Company Information
    Table 58. Merial Introduction and Business Overview
    Table 59. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 60. Merial Avian Influenza Vaccines Product Offerings
    Table 61. Merial Recent Development
    Table 62. QYH Biotech Company Information
    Table 63. QYH Biotech Introduction and Business Overview
    Table 64. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 65. QYH Biotech Avian Influenza Vaccines Product Offerings
    Table 66. QYH Biotech Recent Development
    Table 67. DHN Company Information
    Table 68. DHN Introduction and Business Overview
    Table 69. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 70. DHN Avian Influenza Vaccines Product Offerings
    Table 71. DHN Recent Development
    Table 72. HVRI Company Information
    Table 73. HVRI Introduction and Business Overview
    Table 74. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 75. HVRI Avian Influenza Vaccines Product Offerings
    Table 76. HVRI Recent Development
    Table 77. CEVA Company Information
    Table 78. CEVA Introduction and Business Overview
    Table 79. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 80. CEVA Avian Influenza Vaccines Product Offerings
    Table 81. CEVA Recent Development
    Table 82. Elanco (Lohmann ) Company Information
    Table 83. Elanco (Lohmann ) Introduction and Business Overview
    Table 84. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 85. Elanco (Lohmann ) Avian Influenza Vaccines Product Offerings
    Table 86. Elanco (Lohmann ) Recent Development
    Table 87. Yebio Company Information
    Table 88. Yebio Introduction and Business Overview
    Table 89. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 90. Yebio Avian Influenza Vaccines Product Offerings
    Table 91. Yebio Recent Development
    Table 92. Zoetis Company Information
    Table 93. Zoetis Introduction and Business Overview
    Table 94. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 95. Zoetis Avian Influenza Vaccines Product Offerings
    Table 96. Zoetis Recent Development
    Table 97. FATRO Company Information
    Table 98. FATRO Introduction and Business Overview
    Table 99. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 100. FATRO Avian Influenza Vaccines Product Offerings
    Table 101. FATRO Recent Development
    Table 102. Kyoto Biken Company Information
    Table 103. Kyoto Biken Introduction and Business Overview
    Table 104. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 105. Kyoto Biken Avian Influenza Vaccines Product Offerings
    Table 106. Kyoto Biken Recent Development
    Table 107. CAVAC Company Information
    Table 108. CAVAC Introduction and Business Overview
    Table 109. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 110. CAVAC Avian Influenza Vaccines Product Offerings
    Table 111. CAVAC Recent Development
    Table 112. Ringpu Biology Company Information
    Table 113. Ringpu Biology Introduction and Business Overview
    Table 114. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 115. Ringpu Biology Avian Influenza Vaccines Product Offerings
    Table 116. Ringpu Biology Recent Development
    Table 117. Vaksindo Company Information
    Table 118. Vaksindo Introduction and Business Overview
    Table 119. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 120. Vaksindo Avian Influenza Vaccines Product Offerings
    Table 121. Vaksindo Recent Development
    Table 122. ChengDu Tecbond Company Information
    Table 123. ChengDu Tecbond Introduction and Business Overview
    Table 124. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 125. ChengDu Tecbond Avian Influenza Vaccines Product Offerings
    Table 126. ChengDu Tecbond Recent Development
    Table 127. Sindh Poultry Vaccine Centre Company Information
    Table 128. Sindh Poultry Vaccine Centre Introduction and Business Overview
    Table 129. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 130. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offerings
    Table 131. Sindh Poultry Vaccine Centre Recent Development
    Table 132. Merck Animal Health Company Information
    Table 133. Merck Animal Health Introduction and Business Overview
    Table 134. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 135. Merck Animal Health Avian Influenza Vaccines Product Offerings
    Table 136. Merck Animal Health Recent Development
    Table 137. Medion Company Information
    Table 138. Medion Introduction and Business Overview
    Table 139. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 140. Medion Avian Influenza Vaccines Product Offerings
    Table 141. Medion Recent Development
    Table 142. Avimex Animal Health Company Information
    Table 143. Avimex Animal Health Introduction and Business Overview
    Table 144. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 145. Avimex Animal Health Avian Influenza Vaccines Product Offerings
    Table 146. Avimex Animal Health Recent Development
    Table 147. JOVAC Company Information
    Table 148. JOVAC Introduction and Business Overview
    Table 149. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 150. JOVAC Avian Influenza Vaccines Product Offerings
    Table 151. JOVAC Recent Development
    Table 152. Bio-Labs Company Information
    Table 153. Bio-Labs Introduction and Business Overview
    Table 154. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 155. Bio-Labs Avian Influenza Vaccines Product Offerings
    Table 156. Bio-Labs Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Avian Influenza Vaccines Downstream Customers
    Table 160. Avian Influenza Vaccines Distributors List
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Avian Influenza Vaccines Product Picture
    Figure 2. Global Avian Influenza Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Avian Influenza Vaccines Sales Volume (2019-2030) & (M Doses)
    Figure 5. Global Avian Influenza Vaccines Sales Price (2019-2030) & (USD/K Doses)
    Figure 6. Avian Influenza Vaccines Report Years Considered
    Figure 7. Global Avian Influenza Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Avian Influenza Vaccines Players Sales Volume Ranking (2023) & (M Doses)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Avian Influenza Vaccines Revenue in 2023
    Figure 10. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. H5+H7 Avian Influenza Vaccines Picture
    Figure 12. H9 Avian Influenza Vaccines Picture
    Figure 13. Global Avian Influenza Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Avian Influenza Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Avian Influenza Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
    Figure 16. Global Avian Influenza Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Avian Influenza Vaccines Price by Type (2019-2030) & (USD/K Doses)
    Figure 18. Product Picture of Chicken Avian Influenza Vaccines
    Figure 19. Product Picture of Duck & Goose Avian Influenza Vaccines
    Figure 20. Product Picture of Other
    Figure 21. Global Avian Influenza Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Avian Influenza Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Avian Influenza Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
    Figure 24. Global Avian Influenza Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Avian Influenza Vaccines Price by Application (2019-2030) & (USD/K Doses)
    Figure 26. North America Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Avian Influenza Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Avian Influenza Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Avian Influenza Vaccines Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Avian Influenza Vaccines Sales Volume (%), (2019-2030)
    Figure 38. United States Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Avian Influenza Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Avian Influenza Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Avian Influenza Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 59. Avian Influenza Vaccines Industrial Chain
    Figure 60. Avian Influenza Vaccines Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS